- Home
- MEGI vs SIBN Comparison
MEGI vs SIBN Comparison
Compare MEGI & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MEGI | SIBN |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 788.0M | 778.8M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MEGI | SIBN |
|---|---|---|
| Price | $15.15 | $18.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $23.88 |
| AVG Volume (30 Days) | 131.5K | ★ 479.7K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,301,000.00 |
| Revenue This Year | N/A | $16.95 |
| Revenue Next Year | N/A | $14.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $13.42 | $11.48 |
| 52 Week High | $15.89 | $21.89 |
Technical Indicators
Market Signals| Indicator | MEGI | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 46.33 | 63.61 |
| Support Level | $14.78 | $18.34 |
| Resistance Level | $15.46 | $19.68 |
| Average True Range (ATR) | 0.25 | 0.73 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 30.85 | 82.63 |
Price Performance
Historical ComparisonAbout MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
NYLI CBRE Global Infrastructure Megatrends Term Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It is focused on the investment megatrends of decarbonization, digital transformation and asset modernization, which are reshaping the demand for infrastructure assets and driving income and growth potential.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.